Literature DB >> 16196178

Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.

Dorairaj Prabhakaran1, Salim Yusuf, Shamir Mehta, Janice Pogue, Alvaro Avezum, Andrzej Budaj, Leszek Cerumzynski, Marcus Flather, Keith Fox, David Hunt, Liu Lisheng, Matyas Keltai, Alexander Parkhomenko, Prem Pais, Srinath Reddy, Mikhail Ruda, Tan Hiquing, Zhu Jun.   

Abstract

BACKGROUND: Acute coronary syndrome continues to have significant long-term morbidity and mortality. This study sought to compare baseline characteristics, practice patterns and clinical outcomes for patients with non-ST elevation acute coronary syndrome from a broad range of low-, middle- and high-income countries. METHODS AND
RESULTS: We compared the data from a prospective registry of patients with non-ST elevation acute coronary syndrome involving 4615 patients from 65 centers in 8 low and middle income countries (OASIS registry 2) with those obtained from 7987 patients from 95 centers in 6 middle and high income countries (OASIS registry 1). Patients in the OASIS registry 2 were younger, were more often males and smokers, presented later to the hospital after symptom onset and had a lower prevalence of diabetes at admission [with the exception of India, which had the highest age-adjusted prevalence (39.1%)]. There were marked variations in the angiography and intervention rates during the hospital stay, but the uses of proven pharmacological therapies were comparable. The two-year mortality rates adjusted for baseline covariates ranged from 6.9% to 15%. Patients from China had the lowest two-year mortality rate (6.9%) and patients from India had the highest rate (15%). Combining the two registries, the covariate-adjusted rate of death or myocardial infarction did not differ across countries with in-hospital angiographic rates of > or = 50% (17.1%), 25-49% (16.7%) or < 25% (16.5%). However, the covariate-adjusted rates for subsequent myocardial infarction (7.6%, 9.2% and 10.8% respectively, p < 0.0001), refractory angina (21.3%, 27.7% and 35.4% respectively, p < 0.0001) and the composite of death, myocardial infarction or refractory angina (34.9%, 40.7% and 46.8% respectively, p < 0.0001) differed depending on the angiographic rates.
CONCLUSIONS: Among the participating countries there was a marked heterogeneity in patient characteristics, coronary interventions, resulting in differences in the two-year composite rates of death, myocardial infarction and refractory angina among patients admitted with non-ST elevation acute coronary syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16196178

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  22 in total

Review 1.  Perspectives on the management of coronary artery disease in India.

Authors:  Ganesan Karthikeyan; Denis Xavier; Doriaraj Prabhakaran; Prem Pais
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

2.  The CRRIS study: beginning of a new era of enquiry and educational intervention in India.

Authors:  Ajay K Sinha
Journal:  Indian Heart J       Date:  2015-03-12

Review 3.  Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.

Authors:  Santanu Guha; Rishi Sethi; Saumitra Ray; Vinay K Bahl; S Shanmugasundaram; Prafula Kerkar; Sivasubramanian Ramakrishnan; Rakesh Yadav; Gaurav Chaudhary; Aditya Kapoor; Ajay Mahajan; Ajay Kumar Sinha; Ajit Mullasari; Akshyaya Pradhan; Amal Kumar Banerjee; B P Singh; J Balachander; Brian Pinto; C N Manjunath; Chandrashekhar Makhale; Debabrata Roy; Dhiman Kahali; Geevar Zachariah; G S Wander; H C Kalita; H K Chopra; A Jabir; JagMohan Tharakan; Justin Paul; K Venogopal; K B Baksi; Kajal Ganguly; Kewal C Goswami; M Somasundaram; M K Chhetri; M S Hiremath; M S Ravi; Mrinal Kanti Das; N N Khanna; P B Jayagopal; P K Asokan; P K Deb; P P Mohanan; Praveen Chandra; Col R Girish; O Rabindra Nath; Rakesh Gupta; C Raghu; Sameer Dani; Sandeep Bansal; Sanjay Tyagi; Satyanarayan Routray; Satyendra Tewari; Sarat Chandra; Shishu Shankar Mishra; Sibananda Datta; S S Chaterjee; Soumitra Kumar; Soura Mookerjee; Suma M Victor; Sundeep Mishra; Thomas Alexander; Umesh Chandra Samal; Vijay Trehan
Journal:  Indian Heart J       Date:  2017-03-23

4.  Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry.

Authors:  Padinhare Purayil Mohanan; Rony Mathew; Sadasivan Harikrishnan; Mangalath Narayanan Krishnan; Geevar Zachariah; Jhony Joseph; Koshy Eapen; Mathew Abraham; Jaideep Menon; Manoj Thomas; Sonny Jacob; Mark D Huffman; Dorairaj Prabhakaran
Journal:  Eur Heart J       Date:  2012-09-07       Impact factor: 29.983

5.  Global perspective on acute coronary syndrome: a burden on the young and poor.

Authors:  Rajesh Vedanthan; Benjamin Seligman; Valentin Fuster
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

Review 6.  Heart failure: epidemiology and prevention in India.

Authors:  Mark D Huffman; Dorairaj Prabhakaran
Journal:  Natl Med J India       Date:  2010 Sep-Oct       Impact factor: 0.537

7.  Sex Differences in the Presentation, Diagnosis, and Management of Acute Coronary Syndromes: Findings From the Kerala-India ACS Registry.

Authors:  Amisha Patel; Sunitha Vishwanathan; Tiny Nair; C G Bahuleyan; V L Jayaprakash; Abigail Baldridge; Mark D Huffman; Dorairaj Prabhakaran; P P Mohanan
Journal:  Glob Heart       Date:  2015-09-26

Review 8.  Diabetes & coronary heart disease: current perspectives.

Authors:  Mohammed K Ali; K M Venkat Narayan; Nikhil Tandon
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

Review 9.  Heart failure in South Asia.

Authors:  Harikrishnan Sivadasan Pillai; Sanjay Ganapathi
Journal:  Curr Cardiol Rev       Date:  2013-05

10.  Association between gender, process of care measures, and outcomes in ACS in India: results from the detection and management of coronary heart disease (DEMAT) registry.

Authors:  Neha J Pagidipati; Mark D Huffman; Panniyammakal Jeemon; Rajeev Gupta; Prakash Negi; Thannikot M Jaison; Satyavan Sharma; Nakul Sinha; Padinhare Mohanan; B G Muralidhara; Sasidharan Bijulal; Sivasubramonian Sivasankaran; Vijay K Puri; Jacob Jose; K Srinath Reddy; Dorairaj Prabhakaran
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.